Novel hepatoselective insulin analog: studies with a covalently linked thyroxyl-insulin complex in humans.
Fariba Shojaee‐Moradie(University of Surrey), R.H. Jones(St Thomas' Hospital), Peter H. Sönksen(St Thomas' Hospital), Erik Sundermann(St Thomas' Hospital), Jake Powrie(Guy's and St Thomas' NHS Foundation Trust), D. Brandenburg(St Thomas' Hospital), M W Spring(St Thomas' Hospital), A. Schüttler(St Thomas' Hospital)
Cited by 45
Related Papers
Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
|Diabetes|2014|244
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
|Science Translational Medicine|2017|215
Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death
|Diabetes|2011|213
Self‐monitoring in Type 2 diabetes mellitus: a meta‐analysis
|Diabetic Medicine|2000|177
Detection of growth hormone abuse in sport
|Growth Hormone & IGF Research|2007|144